Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Fairhope. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Fairhope at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This study consists of a screening, a 4-week dapagliflozin run-in period for participants naïve to SGLT2i at baseline; a 24-month double-blind period in which participants will receive either baxdrostat/dapagliflozin or dapagliflozin; and a 6-week open-label period in which all participants will discontinue baxdrostat/placebo and receive dapagliflozin a
Sponsor: AstraZeneca
Check if you qualify for this chronic kidney disease clinical trial in Fairhope, AL
If you're searching for chronic kidney disease treatment options in Fairhope, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairhope research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.